Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.13
|
1.16
|
0.9001
|
0.9001
|
1.32
|
1.14
|
|
|
308 569.25
|
742.00
|
0.88
|
0.895
|
0.81
|
0.81
|
0.923
|
0.871201
|
|
|
91 722.37
|
323.00
|
0.7901
|
0.8066
|
0.7201
|
0.7201
|
0.927
|
0.80
|
|
|
144 737.39
|
688.00
|
0.72
|
0.74
|
0.5541
|
0.43
|
0.85
|
0.73
|
|
|
365 651.82
|
1 283.00
|
0.601
|
0.613
|
1.14
|
0.55
|
1.14
|
0.6162
|
|
|
762 351.22
|
2 255.00
|
1.31
|
1.32
|
1.44
|
1.35
|
2.01
|
1.42
|
|
|
2 038 010.43
|
5 965.00
|
1.36
|
1.37
|
1.04
|
0.99
|
1.38
|
1.33
|
|
|
348 537.08
|
1 097.00
|
1.00
|
1.03
|
1.08
|
0.92
|
1.08
|
1.0191
|
|
|
189 785.41
|
645.00
|
1.13
|
1.15
|
0.8325
|
0.8325
|
1.20
|
1.16
|
|
|
307 941.90
|
1 283.00
|
0.812
|
0.83
|
0.845
|
0.80
|
0.87
|
0.8255
|
|
|
78 732.82
|
425.00
|
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.